Maternity staff immunization coverage against pertussis and maternal vaccination practices: Results of a 2017 cross-sectional survey in five public maternity hospitals.


Journal

Medecine et maladies infectieuses
ISSN: 1769-6690
Titre abrégé: Med Mal Infect
Pays: France
ID NLM: 0311416

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 09 10 2018
revised: 01 04 2019
accepted: 12 07 2019
pubmed: 4 8 2019
medline: 25 8 2021
entrez: 4 8 2019
Statut: ppublish

Résumé

To conduct an audit of vaccination practices against pertussis in maternity wards to assess immunization practices targeting women, knowledge and awareness among health professionals and their involvement in the vaccination process, and to estimate their vaccine coverage. 2017 cross-sectional descriptive survey using a data collection sheet of immunization practices targeting women and an anonymous questionnaire for health professionals whose vaccine coverage had been documented by the occupational health service. Five public maternity wards participated: one had a vaccination policy for women; 426 of 822 health professionals completed the questionnaire, 76% (from 50% of all residents to 83% of nurses) declared their vaccination status as up to date. Staff files in occupational health services showed that 69% of 822 health professionals received at least one vaccine booster during adulthood (57% less than 10 years before the survey); documented vaccination coverage rates ranged from 75% for residents to 91% for senior physicians. Occupational physicians and family physicians respectively performed 41% and 34% of vaccinations. While knowledge regarding vaccines was good, only 47% of health professionals declared prescribing them and 18% declared administering the anti-pertussis vaccine "often" or "very often". Updated data is needed to confirm the reported increase as participating centers are not representative of all birth centers. The active role of health professionals in vaccination-based pertussis prevention needs to be reinforced.

Identifiants

pubmed: 31375373
pii: S0399-077X(18)30918-1
doi: 10.1016/j.medmal.2019.07.009
pii:
doi:

Substances chimiques

Pertussis Vaccine 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-367

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

G Pellissier (G)

Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France. Electronic address: gerard.pellissier@geres.org.

I Lolom (I)

Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France; Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.

N Cairati (N)

Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France; Hôpital Beaujon AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France.

C Cherifi (C)

Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.

C Amiel-Taieb (C)

Hôpital Beaujon AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France.

S Farbos (S)

Centre Hospitalier de la Côte Basque, 13, avenue de l'Interne Jacques Loeb, 64100 Bayonne, France; Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France.

V Caillaud (V)

Centre Hospitalier de la Côte Basque, 13, avenue de l'Interne Jacques Loeb, 64100 Bayonne, France.

J Gaudelus (J)

Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France; Hôpital Jean-Verdier AP-HP, avenue du 14 juillet, 93140 Bondy, France.

C Gozlan (C)

Hôpital Jean-Verdier AP-HP, avenue du 14 juillet, 93140 Bondy, France.

D Pinquier (D)

Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France; CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France.

J F Gehanno (JF)

CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France.

D Luton (D)

Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.

E Bouvet (E)

Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France; Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France.

D Abiteboul (D)

Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France; Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH